 |
인쇄하기
취소
|
KFDA approves 10 Baraclude generics
Ten Korean pharmaceutical firms, including CJ Pharm, SK Chemicals and Hanmi Pharm, are allowed to produce generic versions of the hepatitis B drug Baraclude, the Korea Food and Drug Administration officials said Thursday.
The health watchdog is also expected to give the go ahead for more local firms.
The U.S. based Bristol-Myers Squibb’s Baraclude, a drug that was launched in 2007 here an...
The health watchdog is also expected to give the go ahead for more local firms.
The U.S. based Bristol-Myers Squibb’s Baraclude, a drug that was launched in 2007 here an...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.